2/17
08:02 am
anro
Alto Neuroscience (NYSE:ANRO) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $28.00 price target on the stock, up previously from $27.00.
High
Report
Alto Neuroscience (NYSE:ANRO) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $28.00 price target on the stock, up previously from $27.00.
2/17
05:55 am
anro
Rating for ANRO
High
Report
Rating for ANRO
1/5
08:14 am
anro
Rating for ANRO
Low
Report
Rating for ANRO